Listed

Artiva Biotherapeutics, Inc.

ARTVNasdaqCIK 1817241HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024
Operating income−$26.9m, Q2 FY2026
Net income−$25.0m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m26.7Revenue, period not labelled, three months to 2023-09-30$26.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure1.8Revenue, period not labelled, three months to 2023-12-31$1.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure0.3Revenue, period not labelled, three months to 2024-03-31$251.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0000950170-25-104045. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-275872. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m13.1Research and development, period not labelled, three months to 2023-09-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure11.2Research and development, period not labelled, three months to 2023-12-31$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure11.2Research and development, period not labelled, three months to 2024-03-31$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure12.3Research and development, Q2 FY2024, three months to 2024-06-30$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure13.5Research and development, Q3 FY2024, three months to 2024-09-30$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure13.3Research and development, Q4 FY2024, three months to 2024-12-31$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure17.1Research and development, Q1 FY2025, three months to 2025-03-31$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure17.9Research and development, Q2 FY2025, three months to 2025-06-30$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure17.6Research and development, Q3 FY2025, three months to 2025-09-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure17.0Research and development, Q4 FY2025, three months to 2025-12-31$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure19.3Research and development, Q1 FY2026, three months to 2026-03-31$19.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure21.9Research and development, Q2 FY2026, three months to 2026-06-30$21.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Operating income$m10.8Operating income, period not labelled, three months to 2023-09-30$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure(12.0)Operating income, period not labelled, three months to 2023-12-31−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Operating income, period not labelled, three months to 2024-03-31−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure(16.2)Operating income, Q2 FY2024, three months to 2024-06-30−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure(18.3)Operating income, Q3 FY2024, three months to 2024-09-30−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(18.3)Operating income, Q4 FY2024, three months to 2024-12-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(22.2)Operating income, Q1 FY2025, three months to 2025-03-31−$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(22.8)Operating income, Q2 FY2025, three months to 2025-06-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(22.9)Operating income, Q3 FY2025, three months to 2025-09-30−$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(21.9)Operating income, Q4 FY2025, three months to 2025-12-31−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(24.4)Operating income, Q1 FY2026, three months to 2026-03-31−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(26.9)Operating income, Q2 FY2026, three months to 2026-06-30−$26.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Net income$m11.3Net income, period not labelled, three months to 2023-09-30$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure(12.0)Net income, period not labelled, three months to 2023-12-31−$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure(14.0)Net income, period not labelled, three months to 2024-03-31−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(17.8)Net income, Q2 FY2024, three months to 2024-06-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(17.5)Net income, Q3 FY2024, three months to 2024-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(16.1)Net income, Q4 FY2024, three months to 2024-12-31−$16.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(20.3)Net income, Q1 FY2025, three months to 2025-03-31−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(21.3)Net income, Q2 FY2025, three months to 2025-06-30−$21.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(21.5)Net income, Q3 FY2025, three months to 2025-09-30−$21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(20.8)Net income, Q4 FY2025, three months to 2025-12-31−$20.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Net income, Q1 FY2026, three months to 2026-03-31−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(25.0)Net income, Q2 FY2026, three months to 2026-06-30−$25.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Diluted EPS$ per share1.62Diluted EPS, period not labelled, three months to 2023-09-30$1.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figurenot reported(17.24)Diluted EPS, period not labelled, three months to 2024-03-31−$17.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure(22.00)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$22.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure(0.92)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figurenot reported(0.83)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(0.87)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(0.88)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figurenot reported(0.95)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(0.63)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Basic EPS$ per share13.98Basic EPS, period not labelled, three months to 2023-09-30$13.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figurenot reported(17.24)Basic EPS, period not labelled, three months to 2024-03-31−$17.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure(22.00)Basic EPS, Q2 FY2024, three months to 2024-06-30−$22.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure(0.92)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figurenot reported(0.83)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(0.87)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure(0.88)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figurenot reported(0.95)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(0.63)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure

Balance sheet

Cash and equivalents$301.5m, Q2 FY2026
Shareholders' equity$347.5m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m65.9Cash and equivalents, period not labelled, at 2023-09-30$65.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure53.5Cash and equivalents, period not labelled, at 2023-12-31$53.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0000950170-25-043837.Report this figure48.2Cash and equivalents, period not labelled, at 2024-03-31$48.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure34.2Cash and equivalents, Q2 FY2024, at 2024-06-30$34.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure55.9Cash and equivalents, Q3 FY2024, at 2024-09-30$55.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure40.2Cash and equivalents, FY2024, at 2024-12-31$40.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure30.4Cash and equivalents, Q1 FY2025, at 2025-03-31$30.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure28.5Cash and equivalents, Q2 FY2025, at 2025-06-30$28.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure25.5Cash and equivalents, Q3 FY2025, at 2025-09-30$25.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure26.7Cash and equivalents, FY2025, at 2025-12-31$26.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure21.0Cash and equivalents, Q1 FY2026, at 2026-03-31$21.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure301Cash and equivalents, Q2 FY2026, at 2026-06-30$301.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Current assets$mnot reported79.8Current assets, period not labelled, at 2023-12-31$79.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043837.Report this figurenot reported49.7Current assets, Q2 FY2024, at 2024-06-30$49.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-29, accession 0001193125-24-209924.Report this figure151Current assets, Q3 FY2024, at 2024-09-30$150.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure189Current assets, FY2024, at 2024-12-31$188.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure170Current assets, Q1 FY2025, at 2025-03-31$170.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure149Current assets, Q2 FY2025, at 2025-06-30$149.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure130Current assets, Q3 FY2025, at 2025-09-30$129.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure113Current assets, FY2025, at 2025-12-31$112.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure88.7Current assets, Q1 FY2026, at 2026-03-31$88.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure352Current assets, Q2 FY2026, at 2026-06-30$352.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Total assets$mnot reported105Total assets, period not labelled, at 2023-12-31$105.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0000950170-25-043837.Report this figurenot reported75.9Total assets, Q2 FY2024, at 2024-06-30$75.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-29, accession 0001193125-24-209924.Report this figure226Total assets, Q3 FY2024, at 2024-09-30$225.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure210Total assets, FY2024, at 2024-12-31$209.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure191Total assets, Q1 FY2025, at 2025-03-31$191.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure169Total assets, Q2 FY2025, at 2025-06-30$169.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure149Total assets, Q3 FY2025, at 2025-09-30$148.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure131Total assets, FY2025, at 2025-12-31$130.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure106Total assets, Q1 FY2026, at 2026-03-31$106.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure369Total assets, Q2 FY2026, at 2026-06-30$368.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Current liabilities$mnot reported12.2Current liabilities, period not labelled, at 2023-12-31$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043837.Report this figurenot reported10.8Current liabilities, Q2 FY2024, at 2024-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-29, accession 0001193125-24-209924.Report this figure13.3Current liabilities, Q3 FY2024, at 2024-09-30$13.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure12.3Current liabilities, FY2024, at 2024-12-31$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure12.2Current liabilities, Q1 FY2025, at 2025-03-31$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure10.8Current liabilities, Q2 FY2025, at 2025-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure11.1Current liabilities, Q3 FY2025, at 2025-09-30$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure13.1Current liabilities, FY2025, at 2025-12-31$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure10.9Current liabilities, Q1 FY2026, at 2026-03-31$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure14.6Current liabilities, Q2 FY2026, at 2026-06-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Total liabilities$mnot reported50.7Total liabilities, period not labelled, at 2023-12-31$50.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0000950170-25-043837.Report this figurenot reported50.6Total liabilities, Q2 FY2024, at 2024-06-30$50.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-29, accession 0001193125-24-209924.Report this figure24.6Total liabilities, Q3 FY2024, at 2024-09-30$24.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure22.9Total liabilities, FY2024, at 2024-12-31$22.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure22.5Total liabilities, Q1 FY2025, at 2025-03-31$22.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure20.4Total liabilities, Q2 FY2025, at 2025-06-30$20.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure19.6Total liabilities, Q3 FY2025, at 2025-09-30$19.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure21.0Total liabilities, FY2025, at 2025-12-31$21.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure18.1Total liabilities, Q1 FY2026, at 2026-03-31$18.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure21.1Total liabilities, Q2 FY2026, at 2026-06-30$21.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure
Shareholders' equity$m(151)Shareholders' equity, period not labelled, at 2023-09-30−$151.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure(162)Shareholders' equity, period not labelled, at 2023-12-31−$162.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-100135.Report this figure(175)Shareholders' equity, period not labelled, at 2024-03-31−$174.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure(191)Shareholders' equity, Q2 FY2024, at 2024-06-30−$191.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure201Shareholders' equity, Q3 FY2024, at 2024-09-30$201.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure187Shareholders' equity, FY2024, at 2024-12-31$186.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure169Shareholders' equity, Q1 FY2025, at 2025-03-31$168.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure149Shareholders' equity, Q2 FY2025, at 2025-06-30$149.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure129Shareholders' equity, Q3 FY2025, at 2025-09-30$129.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure110Shareholders' equity, FY2025, at 2025-12-31$110.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure87.8Shareholders' equity, Q1 FY2026, at 2026-03-31$87.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure348Shareholders' equity, Q2 FY2026, at 2026-06-30$347.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure

Cash flow

Operating cash flow−$20.4m, Q2 FY2026
Capital expenditure$415.0k, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(10.7)Operating cash flow, period not labelled, three months to 2023-09-30−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125382. Derived: 9-month figure less the 6-month figure.Report this figure(10.7)Operating cash flow, period not labelled, three months to 2023-12-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure(15.1)Operating cash flow, period not labelled, three months to 2024-03-31−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure(13.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$13.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-104045. Derived: 6-month figure less the 3-month figure.Report this figure(11.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275872. Derived: 9-month figure less the 6-month figure.Report this figure(14.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(19.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(23.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338029. Derived: 6-month figure less the 3-month figure.Report this figure(19.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275872. Derived: 9-month figure less the 6-month figure.Report this figure(14.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure(21.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure(20.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$20.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338029. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, period not labelled, three months to 2023-09-30$179.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125382. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, period not labelled, three months to 2023-12-31$636.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0000950170-25-043837. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2024-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$464.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-104045. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$96.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-275872. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure0.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$511.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure1.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338029. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q3 FY2025, three months to 2025-09-30$600.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-275872. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$421.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-100135. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$242.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$415.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338029. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)39.41m, Q2 FY2026
Line itemUnitperiod not labelled2023-06-30period not labelled2023-09-30period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.8Diluted shares (weighted), period not labelled, three months to 2023-06-30800,889 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-29, accession 0001193125-24-209924.Report this figure7.0Diluted shares (weighted), period not labelled, three months to 2023-09-306,967,099 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125382.Report this figure0.8Diluted shares (weighted), period not labelled, three months to 2024-03-31809,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066421.Report this figure0.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30811,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-104045.Report this figure18.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3018,896,829 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure24.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3124,341,978 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure24.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3024,378,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure24.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3024,481,722 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-275872.Report this figure24.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3124,678,420 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213242.Report this figure39.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3039,413,236 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure

Shares outstanding: 48.89mShares outstanding, period not labelled, at 2026-07-3148,890,121 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338029.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.